OPKO Health (OPK) Reports In-Line Q4 EPS

OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.11), in-line with the analyst estimate of ($0.11). Revenue for the quarter came in at $185.4 million versus the consensus estimate of $168.21 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.

You May Also Be Interested In

• Home Depot beats estimates, reaffirms fiscal 2026 guidance
• Norwegian Cruise Line Holdings (NYSE: NCLH) PT Raised to $20 at UBS
• VNET Group (VNET) Misses Q2 EPS by 164c